老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enanta Pharmaceuticals Inc.

13.16
-0.0700-0.53%
成交量：18.80万
成交额：247.49万
市值：3.82亿
市盈率：-5.06
高：13.31
开：13.19
低：13.02
收：13.23
52周最高：17.15
52周最低：5.88
股本：2,901.85万
流通股本：2,083.05万
量比：0.87
换手率：0.90%
股息：- -
股息率：- -
每股收益(TTM):-2.6000
每股收益(LYR):-3.8381
净资产收益率：-59.00%
总资产收益率：-11.84%
市净率：3.28
市盈率(LYR):-3.43

数据加载中...

总览公司新闻资讯公告
2020/06/30

重要事件披露

8-K - Current report
2020/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/03/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/02

重要事件披露

Current report, item 5.07
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/02/06

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/23

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/27

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2019/11/21

重要事件披露

Current report, items 2.02 and 9.01
2019/09/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/09

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/06

重要事件披露

Current report, items 2.02 and 9.01
2019/06/26

持股变动声明

Statement of changes in beneficial ownership of securities
2019/05/10

季度报告

Quarterly report [Sections 13 or 15(d)]
更多